Eton Pharmaceuticals, Inc. (ETON) Stock Price & Analysis
Eton Pharmaceuticals, Inc. (ETON) fell 2.42% to USD 58.45 as of September 8, 2026 at 07:35 UTC, according to Nexqual real-time market data.
ETON last closed at USD 58.45; the session ranged USD 56.93–59.95 on volume of 521,603 shares. Market capitalization is —, with a 52-week range of USD 14.27–66.37 (NGM). Source: Nexqual, September 8, 2026 at 07:35 UTC.
Key Statistics (as of September 8, 2026 at 07:35 UTC)
| Price | USD 58.45 |
|---|---|
| Change | ▼ 2.42% (down) |
| Previous Close | USD 58.45 |
| Open | USD 58.45 |
| Day Range | USD 56.93 – 59.95 |
| 52-Week Range | USD 14.27 – 66.37 |
| Volume | 521,603 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (ETON)
Nexqual's technical model rates ETON "STRONG BUY" based on 6 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 07:35 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.29 (neutral) |
| vs SMA50 | Above (USD 47.74) |
| MACD | 3.99 (positive) |
From Eton Pharmaceuticals, Inc.'s Latest SEC 10-K Filing (filed 2026-03-19)
Key Strengths & Strategy (as disclosed to the SEC)
- For example, if we change the manufacturer of a product or our API, the FDA may require stability or other data from the new manufacturer.
- We also rely on our trade secrets, know-how and continuing technological innovation to develop and maintain our proprietary position.
- If we do not comply with applicable requirements, we may be fined, the government may refuse to approve our marketing applications or allow us to manufacture or market our products, and we may be criminally prosecuted.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | USD 5.34 | ▼ 0.74% |
| FENC | Fennec Pharmaceuticals Inc. | USD 12.39 | ▲ 0.65% |
| VRCA | Verrica Pharmaceuticals Inc. | USD 5.3 | ▼ 1.67% |
| LQDA | Liquidia Corporation | USD 68.66 | ▼ 1.46% |
| HYPD | Hyperion DeFi, Inc. | USD 3.3 | ▲ 7.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:35 UTC. This page is informational and not investment advice.